July 2026
Added to Dediabetes Jul 12, 2026RCTs
This randomized controlled trial investigated the effects of the dietary supplement EDC-HHA01 on metabolic health, finding significant reductions in HbA1c and insulin levels compared to placebo.
Interventions
Synbiotic Formulation EDC-HHA01
Outcomes
Exploratory patient-reported measuresFasting insulin levelsHbA1c+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
Interventions
Oral multivitamins and multiminerals (OMVM)
Outcomes
Adverse events incidenceAll-cause mortalityComposite of CV death, non-fatal myocardial infarction, or non-fatal stroke+4 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated the impact of lixisenatide on aortic pulse wave velocity in patients with CKD and type 2 diabetes, finding no significant changes.
Interventions
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)
Outcomes
AlbuminuriaChange in aortic pulse wave velocity from baseline to week 24HbA1c
Added to Dediabetes Jul 12, 2026RCTs
This study investigated the effects of Luseogliflozin combined with leucine-enriched amino acid supplementation and exercise in older adults with type 2 diabetes. It found a decrease in HbA1c and body weight over 52 weeks.
Interventions
Luseogliflozin
Outcomes
Body fat massBody weightFive-times Sit-to-Stand Test+3 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated the impact of a diabetes-specific protein supplement (DSPS) as a partial breakfast replacement on glycemic control in adults with type 2 diabetes, finding significant reductions in postprandial glucose levels.
Interventions
Diabetes-specific nutritional formula-pro (DSNF-Pro)Isocaloric control breakfast
Outcomes
Glucose iAUC (OGTT)Mean amplitude of glycemic excursions (MAGE)Postprandial blood glucose+2 more
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated the effects of empagliflozin on glycemic control in adults with HNF1A-MODY, finding significant reductions in glucose levels and improvements in time in range.
Interventions
Empagliflozin
Outcomes
Body weightFasting Plasma Glucose (FPG)Hypoglycemia events+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of extra virgin olive oil supplementation in women with gestational diabetes, finding significant reductions in insulin requirements and neonatal complications.
Interventions
Extra virgin olive oil supplementation
Outcomes
BMIGestational age at delivery (weeks)Gestational weight gain+4 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effectiveness of insulin glargine-lixisenatide fixed-ratio combination (iGlarLixi) in individuals with type 2 diabetes. It found significant improvements in body weight, BMI, and insulin dosage compared to multiple daily injections (MDI).
Interventions
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)
Outcomes
Body Mass Index (BMI) changeGlycemia risk indexHbA1c+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.
Interventions
Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)
Outcomes
Cost-effectiveness assessmentDietary intake changesGestational diabetes mellitus incidence+2 more
Added to Dediabetes Jul 12, 2026RCTs
A study found that supervised home-based elastic band exercises significantly improved health outcomes in pre-frail older adults with type 2 diabetes.
Interventions
Home-based elastic band exercise
Outcomes
Chair standsFrailty score improvementHandgrip Strength+6 more